Software solutions provider WaveDancer and medical technology company Firefly Neuroscience have signed a definitive merger agreement, in an all-stock transaction.

Per the agreement terms, every existing Firefly common stock share will be transformed into WaveDancer common stock at a fixed exchange ratio.

After the merger takes effect, Firefly’s security holders will hold roughly 92% of the merged company while WaveDancer’s security holders will own approximately 8%, on a fully diluted basis.

Once the deal is completed, the merged entity is expected to function under the name Firefly Neuroscience, Inc.

The combined company will focus on advancing and commercialising Firefly’s artificial intelligence-powered Brain Network Analytics (BNA) platform.

This platform has already received approval from the US Food and Drug Administration (FDA). It is used for objectively evaluating brain function by comparing patient electroencephalograms (EEGs) with a database of EEGs and behavioural data.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Psychiatrists and neurologists in the US use BNA for diagnosing mental illnesses and cognitive disorders, enhancing patient compliance with therapy and optimising treatment care pathways.

Firefly CEO Jon Olsen said: “As a publicly traded company, we can continue to drive innovation and bolster our commercialisation efforts while providing existing and new shareholders with the opportunity to participate in our growth story.”

Subject to customary closing conditions, including approvals by the stockholders of each company, the deal is anticipated to be completed in the first quarter of next year.

WaveDancer will sell its operating subsidiary, Tellenger, a company that offers modernisation services to the federal government, in a transaction that will close simultaneously with the Firefly merger.